Product Information
HYDROXYZINE PAM 25 MG CAP is a generic product labeled by Major Pharmaceuticals, priced at $0.0642 per EA under NDC 00904706561. Its NADAC has been published 288 times since Dec 23, 2020.
The Low Outlier badge above means this manufacturer's average price in the hydroxyzine pamoate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904706561
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA201507On Market Since
6/3/2013
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 25 MG CAP has been published 288 times since Dec 23, 2020, and over the history we have for it it has declined 11.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0642 per EA |
|---|---|
| All-time high | $0.0778 (Dec 13, 2023) |
| All-time low | $0.0541 (Nov 20, 2024) |
| 52-week high | $0.0655 |
| 52-week low | $0.0630 |
| Median price | $0.0709 |
| Average price | $0.0686 |
| Largest weekly change | -15.9% (Nov 20, 2024) |
| Weeks tracked | 288 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 25 MG CAP, manufactured by Major Pharmaceuticals, is $0.0642 per EA (NDC 00904706561), effective Jun 24, 2026.
How has the price of HYDROXYZINE PAM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 25 MG CAP has declined 11.2%. It has been tracked across 288 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 25 MG CAP?
Since Dec 23, 2020, the NADAC for HYDROXYZINE PAM 25 MG CAP has ranged from a low of $0.0541 (Nov 20, 2024) to a high of $0.0778 (Dec 13, 2023), with a median of $0.0709 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 25 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROXYZINE PAM 25 MG CAP, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 25 MG CAP?
HYDROXYZINE PAM 25 MG CAP (NDC 00904706561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification